Altimmune, Inc. (NASDAQ: ALT), a biopharmaceutical company making strides in the treatment of liver diseases, has captured the attention of investors with its notable 412.82% potential..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention in the biotechnology sector with its promising pipeline focused on transformative cell and exosome-based therapies. Headquartered in San..
Beta Bionics, Inc. (NASDAQ: BBNX), a promising player in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative solutions for..
Intellia Therapeutics, Inc. (NASDAQ: NTLA), a prominent player in the biotechnology sector, is making waves with its groundbreaking work in curative genome editing treatments. As a..
Weave Communications, Inc. (NASDAQ: WEAV) offers an intriguing opportunity for investors seeking exposure in the healthcare technology sector. With a market capitalization of $419.98 million, Weave..
HealthStream, Inc. (NASDAQ: HSTM) stands as a prominent player in the healthcare information services sector, providing an array of Software-as-a-Service (SaaS) solutions tailored for healthcare organizations..
AxoGen, Inc. (NASDAQ: AXGN), a key player in the medical devices industry, is drawing significant investor attention with its focus on peripheral nerve regeneration and repair..
Arvinas, Inc. (NASDAQ: ARVN) is capturing the attention of investors seeking transformative opportunities in the biotechnology sector. With a market capitalization of $706.47 million, this clinical-stage..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is generating considerable buzz among investors with its strong potential upside of 28.6%, according to recent analyst ratings. This clinical-stage pharmaceutical..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is turning heads in the healthcare investment community, with its promising potential upside of 225.93% spotlighting the biopharmaceutical company as a..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with its promising potential upside of 82.07%, as revealed by recent analyst ratings. Headquartered..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a burgeoning entity in the biotechnology sector, has been turning heads with its impressive revenue growth trajectory. Positioned within the..
Investors seeking high-growth potential in the biotechnology sector might find REGENXBIO Inc. (NASDAQ: RGNX) an intriguing option. This clinical-stage biotech firm, headquartered in Rockville, Maryland, is..
Nurix Therapeutics, Inc. (NASDAQ: NRIX), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to cancer and autoimmune disease therapies...
Vir Biotechnology, Inc. (NASDAQ: VIR) has emerged as a compelling player in the biotechnology sector, attracting significant attention from investors due to its promising pipeline and..
LifeMD, Inc. (NASDAQ: LFMD) is gaining considerable attention in the healthcare sector, particularly with its role as a direct-to-patient telehealth provider. The New York-based company offers..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug discovery and..
Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is capturing attention with its significant growth..
Sionna Therapeutics, Inc. (SION) has been capturing investors’ interest with its pioneering approach in the biotech sector, specifically targeting cystic fibrosis treatment. With a market capitalization..
RxSight, Inc. (NASDAQ: RXST) has emerged as an intriguing player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $304.55..
